Cargando…
α-Glucosidase Inhibitor Can Effectively Inhibit the Risk of Tuberculosis in Patients with Diabetes: A Nested Case-Control Study
Diabetes mellitus (DM) and tuberculosis (TB) are major public health and economic burdens. DM increases Mycobacterium tuberculosis (M.tb) infection rates and treatment durations. This study evaluated the relationship between five classes of oral DM medications and TB infection risk in DM patients. W...
Autores principales: | Lin, Kai-Huang, Luo, Ci-Wen, Chen, Shih-Pin, Tu, Dom-Gene, Lin, Ming-Shian, Kuan, Yu-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254087/ https://www.ncbi.nlm.nih.gov/pubmed/32509871 http://dx.doi.org/10.1155/2020/8085106 |
Ejemplares similares
-
Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study
por: Wu, Sheng-Wen, et al.
Publicado: (2021) -
Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase
por: Riyaphan, Jirawat, et al.
Publicado: (2018) -
QSAR Studies on Andrographolide Derivatives as α-Glucosidase Inhibitors
por: Xu, Jun, et al.
Publicado: (2010) -
Association between Ultraviolet B Exposure Levels and Depression in Taiwanese Adults: A Nested Case–Control Study
por: Luo, Ci-Wen, et al.
Publicado: (2022) -
α-Glucosidase inhibitors and their use in clinical practice
por: Derosa, Giuseppe, et al.
Publicado: (2012)